Combining DNA-microarray data in systemic lupus erythematosus

Por Verweij, Cornelis L, Vosslamber, Saskia
Publicado em 2011

Moving towards personalized medicine in rheumatoid arthritis

Por de Jong, Tamarah D, Vosslamber, Saskia, Verweij, Cornelis L
Publicado em 2014

Type I interferon response gene expression in established rheumatoid arthritis is not associated with clinical parameters

Por de Jong, Tamarah D., Blits, Marjolein, de Ridder, Sander, Vosslamber, Saskia, Wolbink, Gertjan, Nurmohamed, Mike T., Verweij, Cornelis L.
Publicado no Arthritis Res Ther (2016)

Using biomarkers to predict progression from clinically isolated syndrome to multiple sclerosis

Por Tossberg, John T, Crooke, Philip S, Henderson, Melodie A, Sriram, Subramaniam, Mrelashvili, Davit, Vosslamber, Saskia, Verweij, Cor L, Olsen, Nancy J, Aune, Thomas M
Publicado em 2013

Effect of prednisone on type I interferon signature in rheumatoid arthritis: consequences for response prediction to rituximab

Por de Jong, Tamarah D, Vosslamber, Saskia, Blits, Marjolein, Wolbink, Gertjan, Nurmohamed, Mike T, van der Laken, Conny J, Jansen, Gerrit, Voskuyl, Alexandre E, Verweij, Cornelis L
Publicado no Arthritis Res Ther (2015)

Gene expression signatures: biomarkers toward diagnosing multiple sclerosis

Por Tossberg, John T., Crooke, Philip S., Henderson, Melodie A., Sriram, Subramaniam, Mrelashvili, Davit, Chitnis, Shilpa, Polman, Chris, Vosslamber, Saskia, Verweij, Cor L., Olsen, Nancy J., Aune, Thomas M.
Publicado em 2011

The interferon type I signature towards prediction of non-response to rituximab in rheumatoid arthritis patients

Por Raterman, Hennie G, Vosslamber, Saskia, de Ridder, Sander, Nurmohamed, Michael T, Lems, Willem F, Boers, Maarten, van de Wiel, Mark, Dijkmans, Ben AC, Verweij, Cornelis L, Voskuyl, Alexandre E
Publicado em 2012

The type I interferon signature in leukocyte subsets from peripheral blood of patients with early arthritis: a major contribution by granulocytes

Por de Jong, Tamarah D., Lübbers, Joyce, Turk, Samina, Vosslamber, Saskia, Mantel, Elise, Bontkes, Hetty J., van der Laken, Conny J., Bijlsma, Johannes W., van Schaardenburg, Dirkjan, Verweij, Cornelis L.
Publicado no Arthritis Res Ther (2016)

Pharmacogenomics of Interferon-ß Therapy in Multiple Sclerosis: Baseline IFN Signature Determines Pharmacological Differences between Patients

Por van Baarsen, Lisa G. M., Vosslamber, Saskia, Tijssen, Marianne, Baggen, Josefien M. C., van der Voort, Laura F., Killestein, Joep, van der Pouw Kraan, Tineke C. T. M., Polman, Chris H., Verweij, Cornelis L.
Publicado em 2008

Changes in peripheral blood lymphocyte subsets during arthritis development in arthralgia patients

Por Lübbers, Joyce, van Beers-Tas, Marian H., Vosslamber, Saskia, Turk, Samina A., de Ridder, Sander, Mantel, Elise, Wesseling, John G., Reijm, Martine, van Hoogstraten, Ingrid M., Bijlsma, Johannes W., van Schaardenburg, Dirkjan, Bontkes, Hetty J., Verweij, Cornelis L.
Publicado no Arthritis Res Ther (2016)

Physiological evidence for diversification of IFNα- and IFNβ-mediated response programs in different autoimmune diseases

Por de Jong, Tamarah D., Vosslamber, Saskia, Mantel, Elise, de Ridder, Sander, Wesseling, John G., van der Pouw Kraan, Tineke C. T. M., Leurs, Cyra, Hegen, Harald, Deisenhammer, Florian, Killestein, Joep, Lundberg, Ingrid E., Vencovsky, Jiri, Nurmohamed, Mike T., van Schaardenburg, Dirkjan, Bultink, Irene E. M., Voskuyl, Alexandre E., Pegtel, D. Michiel, van der Laken, Conny J., Bijlsma, Johannes W. J., Verweij, Cornelis L.
Publicado no Arthritis Res Ther (2016)